SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-008887
Filing Date
2022-02-23
Accepted
2022-02-23 13:10:38
Documents
12
Period of Report
2022-02-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea156089-8k_inmedpharma.htm   iXBRL 8-K 35276
  Complete submission text file 0001213900-22-008887.txt   209448

Data Files

Seq Description Document Type Size
2 XBRL LABEL FILE inm-20220211_lab.xml EX-101.LAB 34476
3 XBRL PRESENTATION FILE inm-20220211_pre.xml EX-101.PRE 22600
4 XBRL SCHEMA FILE inm-20220211.xsd EX-101.SCH 3039
6 EXTRACTED XBRL INSTANCE DOCUMENT ea156089-8k_inmedpharma_htm.xml XML 3617
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 22662290
SIC: 2834 Pharmaceutical Preparations